Face-name associative memory performance is related to amyloid burden in normal elderly

Neuropsychologia

Volumn 49, Issue 9, 2011, Pages 2776-2783

  Rentz, Dorene M ^a   Amariglio, Rebecca E ^a   Becker, J Alex ^a   Frey, Meghan ^a   Olson, Lauren E ^a   Frishe, Katherine ^a   Carmasin, Jeremy ^a   Maye, Jacqueline E ^a   Johnson, Keith A ^a   Sperling, Reisa A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Amyloid imaging; Early detection; Normal aging; Preclinical Alzheimer's disease

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B;

ADULT; AGED; AGING; ARTICLE; ASSOCIATIVE MEMORY; COGNITION; FACE NAME ASSOCIATIVE MEMORY EXAM; FEMALE; FRONTAL CORTEX; HUMAN; INTELLIGENCE QUOTIENT; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PARIETAL CORTEX; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRECUNEUS;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; ASSOCIATION LEARNING; CEREBRAL CORTEX; COGNITION; FACE; FEMALE; HUMANS; MALE; MEMORY DISORDERS; POSITRON-EMISSION TOMOGRAPHY; REFERENCE VALUES; RETENTION (PSYCHOLOGY); THIAZOLES; VERBAL LEARNING;

EID: 79960165606     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2011.06.006     Document Type: Article

References (72)

1. Aizenstein H.J., Nebes R.D., Saxton J.A., Price J.C., Mathis C.A., Tsopelas N.D., et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Archives of Neurology 2008, 65(11):1509-1517.
2. Albert M.S., Moss M.B., Tanzi R., Jones K. Preclinical prediction of AD using neuropsychological tests. Journal of the International Neuropsychological Society 2001, 7(5):631-639.
3. Archer H.A., Edison P., Brooks D.J., Barnes J., Frost C., Yeatman T., et al. Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C-PIB Positron Emission Tomography Study. Annals of Neurology 2006, 60(1):145-147.
4. Becker J.A., Hedden T., Carmasin J., Maye J., Rentz D.M., Putcha D., et al. Amyloid-β associated cortical thinning in clinically normal elderly. Annals of Neurology 2011, Article first published online: 17 March 2011.
5. Bennett D.A., Schneider J.A., Arvanitakis Z., Kelly J.F., Aggarwal N.T., Shah R.C., et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006, 66(12):1837-1844. 10.1212/01.wnl.0000219668.47116.e6.
6. Blacker D., Lee H., Muzikansky A., Martin E.C., Tanzi R., McArdle J.J., et al. Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Archives of Neurology 2007, 64(6):862-871. 10.1001/archneur.64.6.862.
7. Blackwell A.D., Sahakian B.J., Vesey R., Semple J.M., Robbins T.W., Hodges J.R. Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2004, 17(1-2):42-48.
8. Buckner R.L., Snyder A.Z., Shannon B.J., LaRossa G., Sachs R., Fotenos A.F., et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. Journal of Neuroscience 2005, 25(34):7709-7717.
9. Cabeza R., Grady C.L., Nyberg L., McIntosh A.R., Tulving E., Kapur S., et al. Age-related differences in neural activity during memory encoding and retrieval: A Positron Emission Tomography Study. Journal of Neuroscience 1997, 17(1):391-400.
10. Caselli R.J., Dueck A.C., Osborne D., Sabbagh M.N., Connor D.J., Ahern G.L., et al. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. New England Journal of Medicine 2009, 361(3):255-263. 10.1056/NEJMoa0809437.
11. Chen P., Ratcliff G., Belle S.H., Cauley J.A., Dekosky S.T., Ganguli M. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2000, 55:1847-1853.
12. Clare L., Wilson B.A., Carter G., Roth I., Hodges J.R. Relearning face-name associations in early Alzheimer's disease. Neuropsychology 2002, 16(4):538-547.
13. Cohen G.D. Why is it difficult to put names to faces?. British Journal of Psychology 1990, 1:249-263.
14. de Jager C.A., Milwain E., Budge M. Early detection of isolated memory deficits in the elderly: The need for more sensitive neuropsychological tests. Psychological Medicine 2002, 32(3):483-491.
15. Elias M.F., Beiser A., Wolf P.A., Au R., White R.F., D'Agostino R.B. The preclinical phase of Alzheimer's disease: A 22 year prospective study of the Framingham cohort. Archives of Neurology 2000, 57:808-813.
16. Fagan A.M., Mintun M.A., Mach R.H., Lee S.Y., Dence C.S., Shah A.R., et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta(42) in humans. Annals of Neurology 2006, 59(3):512-519.
17. Fletcher P.C., Henson R.N. Frontal lobes and human memory: Insights from functional neuroimaging. Brain 2001, 124(Pt 5):849-881.
18. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
19. Fowler K.S., Saling M.M., Conway E.L., Semple J.M., Louis W.J. Paired associate performance in the early detection of DAT. Journal of the International Neuropsychological Society 2002, 8(1):58-71.
20. Gomperts S.N., Rentz D.M., Moran E., Becker J.A., Locascio J.J., Klunk W.E., et al. Imaging amyloid deposition in Lewy body diseases. Neurology 2008, 71(12):903-910.
21. Greicius M.D., Srivastava G., Reiss A.L., Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(13):4637-4642.
22. Grober E., Hall C.B., Lipton R.B., Zonderman A.B., Resnick S.M., Kawas C. Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. Journal of the International Neuropsychological Society 2008, 14(2):266-278.
23. Grober E., Merling A., Heimlich T., Lipton R.B. Free and cued selective reminding and selective reminding in the elderly. Journal of Clinical and Experimental Neuropsychology 1997, 19(5):643-654.
24. Hedden T., Van Dijk K.R., Becker J.A., Mehta A., Sperling R.A., Johnson K.A., et al. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. Journal of Neuroscience 2009, 29(40):12686-12694. 10.1523/JNEUROSCI.3189-09.2009.
25. Jack C.R., Lowe V.J., Senjem M.L., Weigand S.D., Kemp B.J., Shiung M.M., et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 2008, 131(Pt 3):665-680.
26. Jackson O., Schacter D.L. Encoding activity in anterior medial temporal lobe supports subsequent associative recognition. Neuroimage 2004, 21(1):456-462. pii: S1053811903006001.
27. Johnson K.A. Amyloid imaging of Alzheimer's disease using Pittsburgh Compound B. Current Neurology and Neuroscience Reports 2006, 6(6):496-503.
28. Johnson K.A., Gregas M., Becker J.A., Kinnecom C., Salat D.H., Moran E.K., et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Annals of Neurology 2007, 62(3):229-234. 10.1002/ana21164.
29. Katzman R., Anderson J.M., Fuld P., Kawas C., Brown T., Morgenstern H., et al. Development of dementing illness in an 80-year-old volunteer cohort. Annals of Neurology 1989, 25:317-324.
30. Kemppainen N.M., Aalto S., Karrasch M., Nagren K., Savisto N., Oikonen V., et al. Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose Positron Emission Tomography in relation to education in mild Alzheimer's disease. Annals of Neurology 2008, 63(1):112-118.
31. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals of Neurology 2004, 55(3):306-319.
32. Leirer V.O., Morrow D.G., Sheikh J.I., Pariante G.M. Memory skills elders want to improve. Experimental Aging Research 1990, 16(3):155-158.
33. Linn R.T., Wolf P.A., Bachman D.L., Knoefel J.E., Cobb J.L., Belanger A.J., et al. The "preclinical phase" of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Archives of Neurology 1995, 52(5):485-490.
34. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. Journal of Cerebral Blood Flow and Metabolism 1996, 16(5):834-840.
35. Lopresti B.J., Klunk W.E., Mathis C.A., Hoge J.A., Ziolko S.K., Lu X., et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: A comparative analysis. Journal of Nuclear Medicine 2005, 46(12):1959-1972.
36. Masur D.M., Fuld P.A., Blau A.D., Thal L.J., Levin H.S., Aronson M.K. Distinguishing normal and demented elderly with the selective reminding test. Journal of Clinical and Experimental Neuropsychology 1989, 11(5):615-630.
37. Mathis C.A., Wang Y., Holt D.P., Huang G.F., Debnath M.L., Klunk W.E. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. Journal of Medicinal Chemistry 2003, 46(13):2740-2754.
38. McWeeny K.H., Young A.W., Hay D.C., Ellis A.W. Putting names to faces. British Journal of Psychology 1987, 78(1):143-149.
39. Miller S.L., Celone K., DePeau K., Diamond E., Dickerson B.C., Rentz D., et al. Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(6):2181-2186.
40. Mintun M.A., Larossa G.N., Sheline Y.I., Dence C.S., Lee S.Y., Mach R.H., et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006, 67(3):446-452.
41. Mormino E.C., Kluth J.T., Madison C.M., Rabinovici G.D., Baker S.L., Miller B.L., et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 2009, 132(Pt 5):1310-1323.
42. Morris J.C. The Clinical Dementia Rating Scale (CDR): Current version and scoring rules. Neurology 1993, 43:2412-2414.
43. Morris J.C., Roe C.M., Grant E.A., Head D., Storandt M., Goate A.M., et al. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Archives of Neurology 2009, 66(12):1469-1475. 10.1001/archneurol.2009.269.
44. Morris J.C., Roe C.M., Xiong C., Fagan A.M., Goate A.M., Holtzman D.M., et al. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Annals of Neurology 2010, 67(1):122-131. 10.1002/ana.21843.
45. Parra M.A., Abrahams S., Logie R.H., Mendez L.G., Lopera F., Della Sala S. Visual short-term memory binding deficits in familial Alzheimer's disease. Brain 2010, 133(9):2702-2713. 10.1093/brain/awq148.
46. Pike K.E., Savage G., Villemagne V.L., Ng S., Moss S.A., Maruff P., et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 2007, 130(Pt 11):2837-2844.
47. Price J.C., Klunk W.E., Lopresti B.J., Lu X., Hoge J.A., Ziolko S.K., et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. Journal of Cerebral Blood Flow and Metabolism 2005, 25(11):1528-1547.
48. Price J.L., Morris J.C. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Annals of Neurology 1999, 45(3):358-368.
49. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(2):676-682. 10.1073/pnas.98.2.676.
50. Reiman E.M., Chen K., Liu X., Bandy D., Yu M., Lee W., et al. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(16):6820-6825.
51. Rentz D.M., Huh T.J., Sardinha L.M., Moran E.K., Becker J.A., Daffner K.R., et al. Intelligence quotient-adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion. Journal of the International Neuropsychological Society 2007, 13(5):821-831. 10.1017/S1355617707071056.
52. Rentz D.M., Locascio J.J., Becker J.A., Moran E.K., Eng E., Buckner R.L., et al. Cognition, reserve, and amyloid deposition in normal aging. Annals of Neurology 2010, 67(3):353-364. 10.1002/ana.21904.
53. Roe C.M., Mintun M.A., D'Angelo G., Xiong C., Grant E.A., Morris J.C. Alzheimer disease and cognitive reserve: Variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. Archives of Neurology 2008, 65(11):1467-1471.
54. Roe C.M., Mintun M.A., Ghoshal N., Williams M.M., Grant E.A., Marcus D.S., et al. Alzheimer disease identification using amyloid imaging and reserve variables: Proof of concept. Neurology 2010, 75(1):42-48. 10.1212/WNL.0b013e3181e620f4.
55. Rugg M.D., Otten L.J., Henson R.N. The neural basis of episodic memory: Evidence from functional neuroimaging. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 2002, 357(1424):1097-1110. 10.1098/rstb.2002.1102.
56. Sheline Y.I., Raichle M.E., Snyder A.Z., Morris J.C., Head D., Wang S., et al. Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biological Psychiatry 2010, 67(6):584-587. 10.1016/j.biopsych.2009.08.024.
57. Sperling R.A., Bates J.F., Chua E.F., Cocchiarella A.J., Rentz D.M., Rosen B.R., et al. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 2003, 74(1):44-50.
58. Sperling R.A., Bates J.F., Cocchiarella A.J., Schacter D.L., Rosen B.R., Albert M.S. Encoding novel face-name associations: a functional MRI study. Human Brain Mapping 2001, 14(3):129-139.
59. Sperling R.A., Chua E., Cocchiarella A., Rand-Giovannetti E., Poldrack R., Schacter D.L., et al. Putting names to faces: Successful encoding of associative memories activates the anterior hippocampal formation. Neuroimage 2003, 20(2):1400-1410.
60. Sperling R.A., Laviolette P.S., O'Keefe K., O'Brien J., Rentz D.M., Pihlajamaki M., et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 2009, 63(2):178-188.
61. Sperling R.A., Aisen P.S., Beckett L.A., Bennett D.A., Craft S., Fagan A., et al. Towards defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer Association Workgroup. Alzheimer's & Dementia 2011, 7(3):280-292.
62. Stern Y. Cognitive reserve. Neuropsychologia 2009, 47(10):2015-2028. 10.1016/j.neuropsychologia.2009.03.004.
63. Storandt M., Mintun M.A., Head D., Morris J.C. Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: Cognitive decline associated with Abeta deposition. Archives of Neurology 2009, 66(12):1476-1481. 10.1001/archneurol.2009.272.
64. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15(1):273-289.
65. Vannini P., O'Brien J., O'Keefe K., Pihlajamaki M., Laviolette P., Sperling R.A. What goes down must come up: Role of the posteromedial cortices in encoding and retrieval. Cerebral Cortex 2010, 10.1093/cercor/bhq051.
66. Vannini P., Hedden T., Becker J.A., Sullivan C., Putcha D., Rentz D., et al. Age and amyloid-related alterations in default network habituation to stimulus repetition. Neurobiology of Aging 2011, 10.1016/j.neurobiolaging.2011.01.003.
67. Villemagne V.L., Pike K.E., Chetelat G., Ellis K.A., Mulligan R.S., Bourgeat P., et al. Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease. Annals of Neurology 2011, 69(1):181-192. 10.1002/ana.22248.
68. Werheid K., Clare L. Are faces special in Alzheimer's disease? Cognitive conceptualisation, neural correlates, and diagnostic relevance of impaired memory for faces and names. Cortex 2007, 43(7):898-906.
69. Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., Adey M., et al. Development and validation of a geriatric depression screening scale. Journal of Psychiatric Research 1983, 17(1):37-49.
70. Yaffe K., Weston A., Graff-Radford N.R., Satterfield S., Simonsick E.M., Younkin S.G., et al. Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA 2011, 305(3):261-266. 10.1001/jama.2010.1995.
71. Zeineh M.M., Engel S.A., Thompson P.M., Bookheimer S.Y. Dynamics of the hippocampus during encoding and retrieval of face-name pairs. Science 2003, 299(5606):577-580. 10.1126/science.1077775.
72. Zelinski E.M., Gilewski M.J. Assessment of memory complaints by rating scales and questionnaires. Psychopharmacology Bulletin 1988, 24(4):523-529.